Partnering

Bringing new medicines to patients in Japan and South Korea (and other APAC countries) offers tremendous potential for growth as part of a global commercialization strategy. However,  the challenges are significant, and range from high costs to the complexities of regional regulations and cultural sensitivities.

Nxera Pharma is committed to being the partner of choice for companies looking to develop and launch innovative medicines in these dynamic markets. Together, we’ll bring innovative treatments to patients across Japan, South Korea and beyond.

Leveraging our extensive expertise, infrastructure and networks in these countries, we will develop and execute strategies that are precisely tailored to the unique requirements of your product in Japan and South Korea. 

Our goal is to improve the probability of development, regulatory and commercialization success, be that designing and implementing registrational clinical trials, securing market approval with optimal access and reimbursement terms, or deploying highly specialized customer-facing teams for your products. 

With our comprehensive support infrastructure, we handle the complexities so you can focus on what matters—delivering groundbreaking therapies.

Our terms are crafted to maximise the value of the product and return on investment whilst protecting the financial health and management efforts of our partners. Partnering with Nxera Pharma ensures that success in the Japan and South Korea markets is both achievable and sustainable.